Sort
21,281 grants matching “influenza”
MOUSE MODELS FOR UNDERSTANDING HOST RESPONSES TO INTRACELLULAR PATHOGENS
$1,549,215Ellen A Robey · University Of California Berkeley · P01 · FY2008 · AI
Modeling Early Immunity to Human Influenza Infection
$1,548,032Stuart C. Sealfon · Icahn School Of Medicine At Mount Sinai · U19 · FY2016 · AI
Understanding Risk of Zoonotic Virus Emergence in EID Hotspots of Southeast Asia
$1,546,744Peter Daszak · Ecohealth Alliance, Inc. · U01 · FY2020 · AI
ELR COMPONENT OF PANDEMIC INFLUENZA GRANT
$1,546,158Paul F. Lewis · Public Health Services · U90 · FY2008 · TP
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,545,308Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2016 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,545,308Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2016 · AI
Core_plus_Option_A_B_Proposal for Influenza Vaccine Effectiveness Research
$1,545,000Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2014 · IP
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large
$1,545,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2014 · IP
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,544,121Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$1,543,286Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2022 · AI
Defining New Human Immunodeficiency and Immunodysregulation Disorders
$1,542,930Helen Su · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Influenza vaccination using a microneedle patch
$1,542,519Mark R Prausnitz · Georgia Institute Of Technology · U01 · FY2010 · EB
Adjuvant discovery for vaccines against West Nile Virus and Influenza
$1,541,329Herman Staats · Duke University · N01 · FY2016 · AI
Animal models and related services (AMRS) core
$1,538,028Padmini Salgame · Rutgers Biomedical And Health Sciences · UC7 · FY2025 · AI
Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing
$1,537,665Suneel Singh · Idt Biologika Gmbh · N01 · FY2024 · AI
1/2 WIN Ratio Analysis to Determine a Strategy of Non-Invasive SUpport for Respiratory Failure in the EmeRgency Department (WINDSURFER)
$1,535,439Henry E Wang · Ohio State University · UG3 · FY2025 · HL
Development of drugs that target the M2 proton channel from the influenza A Virus
$1,535,177William F Degrado · University Of Pennsylvania · U01 · FY2009 · AI
Pathogenesis and Treatment of HIV Infection
$1,532,886H. Clifford Lane · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
MOUSE MODELS FOR UNDERSTANDING HOST RESPONSES TO INTRACELLULAR PATHOGENS
$1,532,128Ellen A Robey · University Of California Berkeley · P01 · FY2007 · AI
Clinical Interventional Studies of HIV Reservoirs
$1,530,173Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Emerging Infectious Diseases Research Center - East and Central Africa
$1,529,810M Kariuki Njenga · Washington State University · U01 · FY2020 · AI
Influenza Immunity: Protective Mechanisms Against Pandemic Respiratory Virus
$1,529,800Mark M Davis · Stanford University · U19 · FY2009 · AI
Vaccine development and production
$1,529,201Sylvain Fleury · University Of Louisiana At Lafayette · U19 · FY2022 · AI
Influenza and Emerging Infectious Diseases
$1,528,179Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
NIAID- VRC- Evaluating mRNA Vaccine Candidates and Capability Development
$1,527,328Barry Gause · Leidos Biomedical Research, Inc. · N01 · FY2022 · AI